YTHDF2 Inhibits Gastric Cancer Cell Growth by Regulating FOXC2 Signaling Pathway
BackgroundGastric cancer (GC) is one of the most common malignancies in the world, and the fourth most frequent malignancy worldwide. YTHDF2 (YTH domain family 2, YTHDF2) binds to mRNA containing m6A, thereby regulating the localization and stability of the bound mRNA. YTHDF2 was shown to be associa...
Main Authors: | Xudong Shen, Kui Zhao, Liming Xu, Guilian Cheng, Jianhong Zhu, Lei Gan, Yongyou Wu, Zhixiang Zhuang |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2021-01-01
|
Series: | Frontiers in Genetics |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fgene.2020.592042/full |
Similar Items
-
YTHDF1 and YTHDF2 are associated with better patient survival and an inflamed tumor-immune microenvironment in non–small-cell lung cancer
by: Kazuo Tsuchiya, et al.
Published: (2021-01-01) -
Up-Regulation of FOXC2 and FOXQ1 Is Associated with The Progression of Gastric-Type Adenocarcinoma
by: Farzad Soleimani, et al.
Published: (2017-05-01) -
The FENDRR/FOXC2 Axis Contributes to Multidrug Resistance in Gastric Cancer and Correlates With Poor Prognosis
by: Hao Liu, et al.
Published: (2021-03-01) -
YTHDF2 reduction fuels inflammation and vascular abnormalization in hepatocellular carcinoma
by: Jiajie Hou, et al.
Published: (2019-11-01) -
FOXC2-AS1 regulates phenotypic transition, proliferation and migration of human great saphenous vein smooth muscle cells
by: Chuang Zhang, et al.
Published: (2019-12-01)